Osborne Clarke advised Delphi Genetics on its acquisition by Catalent
International legal practice Osborne Clarke has advised Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and...
Published on
25/02/2021
Read time
1m